An Early Prosthetic Valve Endocarditis in Presence of COVID-19-Associated Pneumonia

Volodymyr V. Popov; Oleksandr O. Bolshak; Valery Zh. Boukarim; Olena V. Khoroshkovata; Olena M. Trembovetska

doi:10.30702/ujcvs/23.31(03)/PBB043-5157

Volodymyr V. Popov National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine https://orcid.org/0000-0002-2851-5589
Oleksandr O. Bolshak National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine https://orcid.org/0000-0002-6089-9594
Valery Zh. Boukarim National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine https://orcid.org/0000-0002-3895-1894
Olena V. Khoroshkovata National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine https://orcid.org/0000-0002-5857-4643
Olena M. Trembovetska National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine https://orcid.org/0000-0003-3923-224X

DOI: https://doi.org/10.30702/ujcvs/23.31(03)/PBB043-5157

Keywords: cardiopulmonary bypass, heart surgery, complicated surgery of prosthetic valve, mitral valve reoperation, progressive heart failure, A-V postoperative block

Abstract

Introduction. Coronavirus disease (COVID-19)-associated pneumonia was a dangerous disease at the beginning of 2021. However, there are almost no records of early infectious endocarditis of prosthetic heart valve in the presence of such a disease. We present an interesting clinical case of successful treatment of complicated pathology.

The COVID-19 outbreak involved unique clinical complications that were superimposed on the progressive heart failure due to prosthetic mitral valve dysfunction (its detachment) which did not allow time for active antiinflammatory therapy. Urgent replacement of the prosthesis made it possible to eliminate the infection and paved the way for successful long-term antibacterial, antifungal and antiviral therapy.

The aim. To determine the features of management of patients with complex clinical pathology: prosthetic valve endocarditis associated with COVID-19 and severe lung inflammation in the early postoperative period.

Case report. This work presents rare clinical case. A 46-year old male patient underwent successful surgery (mitral valve replacement with posterior leaflet preservation and left atrium resection) at the Department of Surgical Treatment of Acquired Heart Diseases of the National Amosov Institute of Cardiovascular Surgery and was discharged in satisfactory condition. One month later, he was hospitalized again and diagnosed with an early infectious endocarditis of prosthetic mitral valve and bilateral polysegmental COVID-19-associated pneumonia. After a week of medicinal preparation (antibacterial therapy), the patient underwent repeat mitral valve replacement in the presence of progressive heart insufficiency due to increasing paravalvular insufficiency. Postoperative period elapsed without significant complications. The patient was discharged in satisfactory condition on day 15 after surgery and primary rehabilitation.

Conclusion. Having a specific etiology, pneumonia significantly damaged mitral prosthesis structures by increasing paravalvular insufficiency. Consequently, the patient underwent life-saving repeat mitral valve replacement in the presence of COVID-19-associated pneumonia and under massive antibacterial treatment which continued for 60 days after the patient’s discharge. An important element of successful treatment of COVID-19-associated pneumonia is the selection of adequate antibacterial, antifungal and antiviral drugs.

References

Pyo WK, Kim HJ, Kim JB, Jung SH, Choo SJ, Chung CH, et al. Comparative Surgical Outcomes of Prosthetic and Native Valve Endocarditis. Korean Circ J. 2021;51(6):504-514. https://doi.org/10.4070/kcj.2020.0448
Liang F, Song B, Liu R, Yang L, Tang H, Li Y. Optimal timing for early surgery in infective endocarditis: a meta-analysis. Interact Cardiovasc Thorac Surg. 2016;22(3):336-345. https://doi.org/10.1093/icvts/ivv368
Arshad V, Talha KM, Baddour LM. Epidemiology of infective endocarditis: novel aspects in the twenty-first century. Expert Rev Cardiovasc Ther. 2022;20(1):45-54. https://doi.org/10.1080/14779072.2022.2031980
Alizadehasl A, Salehi P, Roudbari S, Peighambari MM. Infectious endocarditis of the prosthetic mitral valve after COVID-19 infection. Eur Heart J. 2020 Dec 21;41(48):4604. https://doi.org/10.1093/eurheartj/ehaa852
Hussain A, Roberts N, Oo A. Prosthetic aortic valve endocarditis complicated by COVID-19 and hemorrhage. J Card Surg. 2020;35(6):1348-1350. https://doi.org/10.1111/jocs.14643
Lalani T, Chu VH, Park LP, Cecchi E, Corey GR, Durante- Mangoni E, et al.; International Collaboration on Endocarditis–Prospective Cohort Study Investigators. In-Hospital and 1-Year Mortality in Patients Undergoing Early Surgery for Prosthetic Valve Endocarditis. JAMA Intern Med. 2013;173(16):1495-1504. https://doi.org/10.1001/jamainternmed.2013.8203
Kang DH, Kim YJ, Kim SH, Sun BJ, Kim DH, Yun SC, et al. Early Surgery versus Conventional Treatment for Infective Endocarditis. N Engl J Med. 2012;366(26):2466-2473. https://doi.org/10.1056/NEJMoa1112843
Chatterjee S, Sardar P. Early surgery reduces mortality in patients with infective endocarditis: insight from a meta-analysis. Int J Cardiol. 2013;168(3):3094-3097. https://doi.org/10.1016/j.ijcard.2013.04.078

An Early Prosthetic Valve Endocarditis in Presence of COVID-19-Associated Pneumonia

Abstract

References

Most read articles by the same author(s)